Marshall Wace, LLP Spruce Biosciences, Inc. Transaction History
Marshall Wace, LLP
- $63.3 Billion
- Q1 2024
A detailed history of Marshall Wace, LLP transactions in Spruce Biosciences, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 72,245 shares of SPRB stock, worth $37,567. This represents 0.0% of its overall portfolio holdings.
Number of Shares
72,245
Previous 105,721
31.66%
Holding current value
$37,567
Previous $309,000
81.55%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding SPRB
# of Institutions
54Shares Held
18.3MCall Options Held
49KPut Options Held
48.1K-
River Vest Venture Management LLC St. Louis, MO2.94MShares$1.53 Million28.35% of portfolio
-
Carlyle Group Inc. Washington, DC2.9MShares$1.51 Million0.17% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD2.61MShares$1.36 Million0.05% of portfolio
-
Abingworth LLP London, X01.79MShares$932,1090.65% of portfolio
-
Aisling Capital Management LP New York, NY1.21MShares$626,8650.33% of portfolio
About SPRUCE BIOSCIENCES, INC.
- Ticker SPRB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 23,560,200
- Market Cap $12.3M
- Description
- Spruce Biosciences, Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapies for rare endocrine disorders. The company engages in developing tildacerfont, a non-steroidal therapy to enhance disease control and reduce steroid burden for adult patients suffering from congenital adrenal hyperplasia (CAH), which i...